Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Jan 3, 3:30PM CST

OLMA : 5.89 (+5.75%)
Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Thu Jan 2, 6:00AM CST

OLMA : 5.89 (+5.75%)
Insider Sale: Director at $OLMA (OLMA) Sells 8,256 Shares Quiver Quantitative, Inc. - Thu Dec 12, 2024

Cyrus Harmon, a director at $OLMA ($OLMA), sold 8,256 shares of the company on 12-10-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares....

OLMA : 5.89 (+5.75%)
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium GlobeNewswire - Tue Dec 10, 2024

OLMA : 5.89 (+5.75%)
Olema Pharmaceuticals Announces FDA Clearance for OP-3136 IND Application, Phase 1 Clinical Trial Set to Begin in Early 2025 Quiver Quantitative, Inc. - Mon Dec 9, 2024

Olema Pharmaceuticals announces FDA clearance for Phase 1 trial of OP-3136, targeting breast cancer treatment.Quiver AI SummaryOlema Pharmaceuticals announced that the U.S. FDA has approved its Investigational...

OLMA : 5.89 (+5.75%)
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor GlobeNewswire - Mon Dec 9, 2024

OLMA : 5.89 (+5.75%)
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Dec 3, 2024

OLMA : 5.89 (+5.75%)
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement GlobeNewswire - Mon Dec 2, 2024

OLMA : 5.89 (+5.75%)
Olema Pharmaceuticals to Present New Data on Palazestrant (OP-1250) at San Antonio Breast Cancer Symposium 2024 Quiver Quantitative, Inc. - Tue Nov 26, 2024

Olema Pharmaceuticals will present Phase 1b/2 data on palazestrant with ribociclib at SABCS 2024.Quiver AI SummaryOlema Pharmaceuticals, Inc. announced that it will present new data from its Phase 1b/2...

OLMA : 5.89 (+5.75%)
Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium GlobeNewswire - Mon Nov 25, 2024

OLMA : 5.89 (+5.75%)

Barchart Exclusives

Confused About Carvana (CVNA)? Try an Overlooked Long Iron Condor Trade. Barchart - Sat Jan 4, 9:15AM CST
After a blistering run from single-digit territory in late 2022, CVNA stock appears to have finally met its match. Here’s how to play the game moving forward. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot